Panelists discuss the critical importance of early biologic therapy initiation in hidradenitis suppurativa to prevent irreversible tissue damage, reduce disease burden, and overcome socioeconomic and ...

Abbvie (($CC:ABBV.CUR)) announced an update on their ongoing clinical study. AbbVie is conducting a Phase 3 clinical study ...

Glucagon-like peptide-1 (GLP-1) receptor agonists show promise in reducing hidradenitis suppurativa severity and pain, especially in patients with obesity.

In this retrospective study, patients who started a GLP-1 agonist experienced significant declines in hidradenitis ...

GLP-1 RA therapy reduces hidradenitis suppurativa severity, flares, symptoms, and BMI in patients with hidradenitis ...

Hidradenitis suppurativa patients face higher depression and anxiety risks, but biologic treatments may reduce these mental ...

1. Hidradenitis suppurativa can be emotionally exhausting. Living with a condition that affects every aspect of your life, including how you dress or your ability to work out, can feel burdensome ...

Hidradenitis suppurativa is usually a clinical diagnosis, meaning doctors can determine if you have it after a physical exam. "When patients come in, we can usually tell right away whether they ...

Hidradenitis suppurativa is associated with a higher risk for new-onset depression and anxiety, which may occur despite treatment, according to a Danish population-based cohort study.